10% OFF

Innovations For Next-Generation Antibody-Drug Conjugates

language: english
Publisher: Springer International Publishing AG, June of 2018 ‧
175,73€
10% OFF CARD
free shipping
Sell ​​your book
While the book primarily addresses ADCs for solid tumors, the last chapter explores the emerging interest in using ADCs to treat other diseases. The therapeutic rationale of ADCs is strong: to direct small molecules to the desired site of action (and away from normal tissues) by conjugation to antibodies or other targeting moieties.

Innovations For Next-Generation Antibody-Drug Conjugates

Property Description
ISBN: 9783319781532
Publisher: Springer International Publishing AG
Release Date: June of 2018
Language: English
Dimensions: 155 x 235 x 20 mm
Cover: Hardcover
Pages: 357
Format: Book
Collection: Cancer Drug Discovery And Development
Categories: Books in English > Medicine > General Medicine
Books in English > Others
EAN: 9783319781532

BOOKS FROM THE SAME COLLECTION